Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
American Healthcare REIT, Inc. Market Cap
Based on ratings from 7 stock analysts, the American Healthcare REIT, Inc. stock price is expected to increase by 7.68% in 12 months. This is calculated by using the average 12-month stock price forecast for American Healthcare REIT, Inc.. The lowest target is $27 and the highest is $36. Please note analyst price targets are not guaranteed and could be missed completely.
About 7 Wall Street analysts have assigned AHR 6 buy ratings, 1 hold ratings, and 0 sell ratings. This means that analysts expect American Healthcare REIT, Inc. to outperform the market. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on AHR. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of AHR.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| Michael Carroll RBC Capital | Outperform | $30 | Maintains | Nov 18, 2024 |
| Michael Lewis Truist Securities | Buy | $29 | Maintains | Nov 15, 2024 |
| Joshua Dennerlein B of A Securities | Buy | $31 | Maintains | Sep 24, 2024 |
| Michael Lewis Truist Securities | Buy | $27 | Maintains | Sep 20, 2024 |
| Aaron Hecht JMP Securities | Market Outperform | $30 | Maintains | Sep 20, 2024 |
| Austin Wurschmidt Keybanc | Overweight | $28 | Maintains | Sep 20, 2024 |
| Austin Wurschmidt Keybanc | Overweight | $27 | Maintains | Sep 16, 2024 |
| Michael Lewis Truist Securities | Buy | $22 | Maintains | Sep 3, 2024 |
| Ronald Kamdem Morgan Stanley | Overweight | $22 | Maintains | Aug 22, 2024 |
| Joshua Dennerlein B of A Securities | Buy | $27 | Maintains | Aug 20, 2024 |
B of A Securities | Buy | $19 | Maintains | Aug 8, 2024 |
| Aaron Hecht JMP Securities | Market Outperform | $18 | Maintains | Aug 7, 2024 |
| Michael Lewis Truist Securities | Buy | $17 | Reiterates | Jul 1, 2024 |
| Aaron Hecht JMP Securities | Market Outperform | $16 | Reiterates | May 16, 2024 |
| Michael Lewis Truist Securities | Buy | $16 | Maintains | Apr 3, 2024 |
| Aaron Hecht JMP Securities | Market Outperform | $16 | Reiterates | Mar 25, 2024 |
| Michael Lewis Truist Securities | Buy | $17 | Reiterates | Mar 25, 2024 |
| Anthony Powell Barclays | Overweight | $18 | Initiates | Mar 14, 2024 |
| Brian Cheng RBC Capital | Outperform | $15 | Initiates | Mar 4, 2024 |
| Aaron Hecht JMP Securities | Market Outperform | $16 | Initiates | Mar 4, 2024 |
When did it IPO
2024
Staff Count
110
Country
United States
Sector/Industry
Real Estate/REIT - Healthcare Facilities
CEO
Mr. Danny Prosky
Market Cap
$4.37B
In 2023, AHR generated $1.86B in revenue, which was a increase of 14.94% from the previous year. This can be seen as a signal that AHR's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Thu, 05 Dec 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - As of Nov. 29, US equity REITs had a median 6.5% discount to net asset value. The hotel sector showed a 21.6% discount, while datacenter REITs had a 27.6% premium.
Why It Matters - The discounts and premiums to net asset value indicate potential undervaluation in hotel REITs and overvaluation in datacenter REITs, signaling investment opportunities and risks.
Tue, 03 Dec 2024
Sentiment - POSITIVE
Source - Seeking Alpha
Summary - REITs may grow as interest rates stabilize, low new supply supports higher rents, and healthcare REITs benefit from strong demand. Multifamily and single-family rentals show regional variability.
Why It Matters - Stabilizing interest rates and low supply enhance REIT growth potential, while strong demand in healthcare and demographic trends support multifamily and single-family rentals.
Tue, 03 Dec 2024
Sentiment - POSITIVE
Source - Zacks Investment Research
Summary - VIK, AHR, and ONB were added to the Zacks Rank #1 (Strong Buy) momentum stocks list on December 3, 2024.
Why It Matters - VIK, AHR, and ONB being rated as Zacks Rank #1 indicates strong growth potential, suggesting favorable investment opportunities and possible stock price appreciation.
Mon, 25 Nov 2024
Sentiment - NEGATIVE
Source - Seeking Alpha
Summary - In October, the REIT sector declined by -3.42%, ending a 5-month winning streak. Large caps fell -3.89%, small caps -4.62%, with 72.90% of REITs posting negative returns.
Why It Matters - The REIT sector's decline signals potential volatility and weakening investor sentiment, which could impact future returns and asset allocation strategies.
Sun, 17 Nov 2024
Sentiment - NEGATIVE
Source - Seeking Alpha
Summary - U.S. equity markets saw their worst week in two months, with the S&P 500 falling 2.1% as interest rates hit four-month highs amid rising inflation data, impacting healthcare and tech stocks.
Why It Matters - Rising interest rates and unexpected inflation data can signal tighter monetary policy, potentially derailing market momentum and impacting sectors like healthcare and technology.
Wed, 13 Nov 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - American Healthcare REIT, Inc. (NYSE:AHR) will host its Q3 2024 results conference call on November 13, 2024, at 12:00 PM ET. Key company executives will participate.
Why It Matters - The scheduled Q3 2024 results call indicates key financial updates and strategic insights from American Healthcare REIT, influencing stock performance and investment decisions.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
